Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Paper mulberry leaf, derived from the plant *Broussonetia papyrifera*, is an herbal medicine investigated for its therapeutic properties. [1] It has a long history of use in Traditional Chinese Medicine to treat conditions such as skin disorders, with reputed effects to "clear heat, cool blood and relieve itching". [12] The leaf extract contains various bioactive compounds, including flavonoids, phenols, and alkaloids, which are believed to contribute to its medicinal effects. [1, 2, 3, 6] Preclinical research in mouse models of psoriasis suggests that paper mulberry leaf extract exerts anti-inflammatory and antioxidant effects. [4, 5, 7] Its mechanism may involve the inhibition of inflammatory signaling pathways such as TLR4/NF-κB and PI3K/AKT, leading to a reduction in pro-inflammatory cytokines like TNF-α, IL-6, and IL-17A. [4, 5, 7] A pilot clinical trial at China Medical University Hospital is evaluating a medicated bath formulation containing paper mulberry leaf, known as Jing-Fu-Yau-Yu-Bau, as a complementary therapy for patients with mild to moderate plaque-type psoriasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on paper mulberry leaf.